Education
About Us
Working with TipRanks
Follow Us
Treatment.com International (TSE:TRUE)
:TRUE
RESEARCH TOOLSreports
TRUE Stock Chart & Stats
Day’s Range― - ―
52-Week RangeC$0.34 - C$1.11
Previous CloseN/A
Volume12.50K
Average Volume (3M)121.61K
Market Cap
$21.46M
Enterprise ValueN/A
Total Cash (Recent Filing)$230.70K
Total Debt (Recent Filing)C$127.17K
Price to Earnings (P/E)―
Beta-1.74
Next Earnings
Aug 27, 2025EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-0.04
Shares Outstanding58,001,495
10 Day Avg. Volume106,313
30 Day Avg. Volume121,608
Financial Highlights & Ratios
PEG Ratio-0.12
Price to Book (P/B)63.94
Price to Sales (P/S)0.00
P/FCF Ratio-4.83
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
Treatment.com International News
PremiumCompany Announcements
Rocket Doctor Joins Heal.LA Accelerator to Boost Virtual Care Access
PremiumCompany Announcements
Rocket Doctor Gains Prestigious Recognition for Health Innovation
PremiumCompany Announcements
Treatment.com AI Grants Stock Options and RSUs to Boost Talent Retention
PremiumCompany Announcements
Rocket Doctor and Melanoma Canada Partner to Enhance Skin Cancer Care Access
PremiumCompany Announcements
Rocket Doctor Wins Clinical Innovator of the Year at NEXUS 2025
PremiumCompany Announcements
Treatment.com AI Completes Acquisition of Rocket Doctor Inc.Options Prices
Currently, No data available
---
Ownership Overview
0.17% Insiders
―
Mutual Funds
― Other Institutional Investors
99.83% Public Companies and
Individual Investors
TRUE FAQ
What was Treatment.com International’s price range in the past 12 months?
Treatment.com International lowest stock price was C$0.34 and its highest was C$1.11 in the past 12 months.
What is Treatment.com International’s market cap?
Treatment.com International’s market cap is $21.46M.
When is Treatment.com International’s upcoming earnings report date?
Treatment.com International’s upcoming earnings report date is Aug 27, 2025 which is in 80 days.
How were Treatment.com International’s earnings last quarter?
Treatment.com International released its earnings results on May 30, 2025. The company reported -C$0.041 earnings per share for the quarter, missing the consensus estimate of N/A by -C$0.041.
Is Treatment.com International overvalued?
According to Wall Street analysts Treatment.com International’s price is currently Overvalued.
Does Treatment.com International pay dividends?
Treatment.com International does not currently pay dividends.
What is Treatment.com International’s EPS estimate?
Treatment.com International’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Treatment.com International have?
Treatment.com International has 58,001,495 shares outstanding.
What happened to Treatment.com International’s price movement after its last earnings report?
Treatment.com International reported an EPS of -C$0.041 in its last earnings report, missing expectations of N/A. Following the earnings report the stock price went up 3.846%.
Which hedge fund is a major shareholder of Treatment.com International?
Currently, no hedge funds are holding shares in TSE:TRUE
Company Description
Treatment.com International
Treatment.Com International Inc. provides personalized health care information services in Canada. It also develops a mobile application for symptom assessment of users to address their health concerns, problems, and ongoing wellness management. The company offers a digital health app, an assessment tool which provides insights about health. In addition, the company provides medical education, medical clinic, and clinical advisor solutions; and offers healthcare information resource. Treatment.Com International Inc. was incorporated in 2018 and is headquartered in Vancouver, Canada.
Technical Analysis
Diagnos
―
Aiml Resources
―
Telecure Technologies Inc
―
Comprehensive Healthcare Systems Inc
―
UniDoc Health Corp
―